Co-Diagnostics, Inc.
CODX
NASDAQ·Healthcare·Biotechnology·Mkt cap $1.3M
$1.16
▲ 0.00%
P/E
—
Mkt Cap
$1.3M
52-Wk Range
$0.94–$46.50
52-Week Range
$0.94 - $46.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 87.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Co-Dx PCR platform enabling portable, rapid diagnostics
- Diverse product portfolio across infectious disease, oncology, and agricultural markets
- Established manufacturing and distribution capabilities for molecular diagnostics
- Early-mover advantage in point-of-care PCR technology commercialization
Bear Case
1 risk
- High volatility (beta 2.9). Larger-than-normal price swings expected.
Growth
Mild headwinds expected
Increasing global demand for decentralized and at-home diagnostic testing
Value
Valuation data unavailable
Momentum
Falling
-77.0% over 3m
Quality
Thin
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CODX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 13, 2026
Reported EPS of -$1.46 vs -$3.00 consensus (+51.3% surprise). Revenue of $166.1K vs $132.6K expected (+25.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+51.3%
Revenue trend · last 8Q
—
—
-80%
-94%
-77%
+77%
+190%
+2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$641.1K
$149.3K
$50.3K
$162.9K
$145.4K
$263.9K
$146.0K
$166.1K
Margins · last 8Q
Gross
72.7%
Profit
-3782.4%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CODX stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related